# Delayed-Value Replay Case Execution

- Run ID: `delayed_value_replay_case_paper_105_review_1_20260602_235500`
- Timestamp UTC: `2026-06-02T15:24:52Z`
- Case ID: `paper_105_review_1`
- Title: `E2ENet: Dynamic Sparse Feature Fusion for Accurate and Efficient 3D Medical Image Segmentation`
- Generation model: `gpt-4o-mini`
- Judge model: `gpt-4o-mini`
- Live model calls: `2`
- Winner short-term: `tie`
- Winner frontier: `tie`
- Model delayed-value label: `positive`
- Deterministic delayed-value label: `mixed_or_inconclusive`

## Scores

| Condition | Short-term | Frontier | Actionability | Specificity | Claim calibration | Overall |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| `paper_only` | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 |
| `raw_review_guided` | 4.0 | 5.0 | 4.0 | 4.0 | 4.0 | 4.0 |
| `six_gate_hybrid_guided` | 4.0 | 5.0 | 5.0 | 4.0 | 4.0 | 4.0 |
| `shuffled_review_control` | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 |

## Strict Label Repair

model judge label was checked against the preregistered delayed-value rule

The raw model label was `positive`, but the deterministic label is `mixed_or_inconclusive` because strict preregistered delayed-value rule not satisfied; guided conditions did not have lower short-term score than paper_only while beating paper_only and shuffled_control on frontier alignment.

## Delayed-Value Rationale

The artifacts demonstrate a clear understanding of the research goals and align well with frontier trends in 3D medical image segmentation, particularly in efficiency and accuracy.

## Condition Rationales

- `paper_only`: The paper-only artifact presents a well-structured hypothesis and method, with a clear experimental plan and expected outcomes. It aligns well with frontier trends in 3D medical segmentation, but lacks some specificity in addressing deployment constraints.
- `raw_review_guided`: This artifact effectively incorporates review signals and aligns closely with frontier trends. It provides actionable insights and maintains a good balance between efficiency and accuracy, though it could further clarify deployment considerations.
- `six_gate_hybrid_guided`: The six-gate hybrid guided artifact excels in actionability and frontier alignment, providing a comprehensive approach to addressing efficiency in segmentation. It effectively outlines the need for empirical evidence in claims, though it shares similar limitations regarding deployment specifics.
- `shuffled_review_control`: The shuffled review control artifact presents a generic approach with less specificity and alignment to frontier trends. While it outlines a valid hypothesis and method, it lacks the depth and actionable insights found in the other artifacts.

## Claim Boundary

This is one live model-generated four-condition mini-paper replay. It scores research-plan artifacts only; it does not rerun medical image segmentation benchmarks, collect human expert ratings, or prove delayed-value review efficacy.
